Human Xtensions
Hand-held Robotic Solutions for Minimally Invasive Surgery
Company Overview
Snapshot
Founded in January 2012, Human Xtensions operates with 11–50 employees and has raised a total of $66 million across three funding rounds from seven investors. The company went public on the TASE in December 2020.
Business overview
Human Xtensions is a medical robotics company that develops software-driven devices designed to enhance minimally invasive surgery. Its core product, HandX, is a lightweight, hand-held device that translates a surgeon’s natural hand motions into complex movements inside the patient, aiming to restore ease and comfort by providing proper ergonomic positioning and increased freedom, flexibility, proximity, and control. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving the global healthcare market.
Strategic signal
In October 2023, Human Xtensions entered into a distribution agreement with a company in Abu Dhabi, signaling strategic expansion into new regional markets. This move indicates the company's efforts to broaden its commercial reach and capitalize on international opportunities for its surgical robotics technology.
Log in to access full profile ›Company Intelligence Q&A
- When did Human Xtensions go public?
- Human Xtensions went public on the TASE in December 2020, raising $48 million in its initial public offering.
- What was a significant product development for Human Xtensions?
- In March 2018, Human Xtensions received FDA 510(k) clearance for HandX, its smart, electro-mechanically simplified surgical system designed to integrate components for a modular platform.
- Has Human Xtensions expanded its market reach recently?
- In October 2023, Human Xtensions entered into a distribution agreement with a company based in Abu Dhabi, aiming to expand its presence in the Middle Eastern market.
- What was a key strategic move for Human Xtensions in 2023?
- In April 2023, Human Xtensions announced a reduction in its US operations, with the goal of saving 31% of expenses.
- Who was appointed CEO of Human Xtensions in 2022?
- Ronen Castro was appointed CEO of Human Xtensions in March 2022.